Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Bos

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Occupational and Environmental Medicine|January 30, 2003
Exposure related mutagens in urine of rubber workers associated with inhalable particulate and dermal exposureR Vermeulen, R P Bos, J Pertijs, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 30, 2000
Weekly patterns in smoking habits and influence on urinary cotinine and mutagenicity levels: confounding effect of nonsmoking policies in the workplaceR Vermeulen, H Wegh, R P Bos, et al.
Cancer Letters|May 1, 1983
Excretion of mutagens in human urine after passive smokingR P Bos, J L Theuws, P T Henderson
Mutation Research|August 1, 1991
Mutagenicity of urine from rats after 1-nitropyrene and 2-nitrofluorene administration using new sensitive Salmonella typhimurium strains YG1012 and YG1024P T Scheepers, J L Theuws, R P Bos
Journal of Applied Toxicology : JAT|April 1, 1991
Urinary cyclophosphamide excretion in rats after intratracheal, dermal, oral and intravenous administration of cyclophosphamideP J Sessink, P H van den Broek, R P Bos
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 1, 2013
alpha-Fluoro beta alanine in urine of workers occupationally exposed to 5 fluorouracil in a 5 fluorouracil producing factoryR P Bos B F J Weissenberger R B M Anzion
Nederlands Tijdschrift Voor Geneeskunde|May 17, 1980
[DNCB, a hazardous medication]R P Bos, R M Brouns, J L Theuws, et al.
Toxicology|January 1, 1982
Studies on the metabolic activation of benzidine by isolated rat hepatocytesR M Brouns, R P Bos, R Van Doorn, et al.
International Archives of Occupational and Environmental Health|January 1, 1982
Mutagenicity of urine from nurses handling cytostatic drugs, influence of smokingR P Bos, A O Leenaars, J L Theuws, et al.
Mutation Research|February 1, 1988
Mutagenicity of bi-, tri- and tetra-cyclic aromatic hydrocarbons in the "taped-plate assay" and in the conventional salmonella mutagenicity assayR P Bos, J L Theuws, F J Jongeneelen, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Occupational and Environmental Medicine|January 30, 2003
Exposure related mutagens in urine of rubber workers associated with inhalable particulate and dermal exposureR Vermeulen, R P Bos, J Pertijs, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 30, 2000
Weekly patterns in smoking habits and influence on urinary cotinine and mutagenicity levels: confounding effect of nonsmoking policies in the workplaceR Vermeulen, H Wegh, R P Bos, et al.
Cancer Letters|May 1, 1983
Excretion of mutagens in human urine after passive smokingR P Bos, J L Theuws, P T Henderson
Mutation Research|August 1, 1991
Mutagenicity of urine from rats after 1-nitropyrene and 2-nitrofluorene administration using new sensitive Salmonella typhimurium strains YG1012 and YG1024P T Scheepers, J L Theuws, R P Bos
Journal of Applied Toxicology : JAT|April 1, 1991
Urinary cyclophosphamide excretion in rats after intratracheal, dermal, oral and intravenous administration of cyclophosphamideP J Sessink, P H van den Broek, R P Bos
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 1, 2013
alpha-Fluoro beta alanine in urine of workers occupationally exposed to 5 fluorouracil in a 5 fluorouracil producing factoryR P Bos B F J Weissenberger R B M Anzion
Nederlands Tijdschrift Voor Geneeskunde|May 17, 1980
[DNCB, a hazardous medication]R P Bos, R M Brouns, J L Theuws, et al.
Toxicology|January 1, 1982
Studies on the metabolic activation of benzidine by isolated rat hepatocytesR M Brouns, R P Bos, R Van Doorn, et al.
International Archives of Occupational and Environmental Health|January 1, 1982
Mutagenicity of urine from nurses handling cytostatic drugs, influence of smokingR P Bos, A O Leenaars, J L Theuws, et al.
Mutation Research|February 1, 1988
Mutagenicity of bi-, tri- and tetra-cyclic aromatic hydrocarbons in the "taped-plate assay" and in the conventional salmonella mutagenicity assayR P Bos, J L Theuws, F J Jongeneelen, et al.
Pageof 10